Form 10-Q OncoMed Pharmaceuticals For: Jun 30
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/2/2026
- Nasdaq hits record high after softer jobs data cuts rate-hike bets
- U.S. economy adds fewer jobs than expected as unemployment rate ticks higher
- Nvidia returns as Morgan Stanley’s Top Pick on attractive valuation
- Citi says rate volatility without Fed repricing is concerning
- U.S. credit-reporting stocks fall as FHFA weighs two-bureau mortgage rule
Oncomed Pharma (OMED) Misses Q2 EPS by 50c
August 7, 2014 8:31 AM EDTOncomed Pharma (NASDAQ: OMED) reported Q2 EPS of ($0.53), $0.50 worse than the analyst estimate of ($0.03). Revenue for the quarter came in at $6 million versus the consensus estimate of $21.28 million.
For earnings history and earnings-related data on Oncomed Pharma (OMED) click here.
... More